EIM
BNTX icon

Essex Investment Management’s BioNTech BNTX Stock Holding History

Essex Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,058
Closed -$2.33M – 397
2021
Q4 		$2.33M Hold
9,058
– – 0.27% 122
2021
Q3 		$2.47M Hold
9,058
– – 0.3% 106
2021
Q2 		$2.03M Hold
9,058
– – 0.24% 139
2021
Q1 		$989K Sell
9,058
-942
-9% -$100K 0.12% 234
2020
Q4 		$815K Buy
+10,000
New +$982K 0.1% 250

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Essex Investment Management's BNTX Position: Q1 2022 in Review

Essex Investment Management sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 9,058 shares — an estimated $2.33M sold.

Essex Investment Management first reported a position in BNTX in Q4 2020 and held it in 5 quarters. The position peaked at $2.47M in Q3 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Essex Investment Management reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Essex Investment Management sold 9,058 BioNTech shares in Q1 2022, an estimated $2.33M.
  • Essex Investment Management first reported a position in BioNTech in Q4 2020 and held it in 5 quarters.
  • Essex Investment Management's BioNTech position peaked at $2.47M in Q3 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Essex Investment Management's 13F filing for Q1 2022, filed 9 May 2022.